On May 28, 2024, Taha Kashout, Chief Technology Officer of GE Healthcare Technologies Inc. (NASDAQ:GEHC), sold 3,300 shares of the company's stock. The transaction was reported in a recent SEC filing. With this sale, the insider now owns 67,300 shares of GE Healthcare Technologies Inc. stock.
GE Healthcare Technologies operates in the healthcare sector and is focused on the development and manufacture of medical imaging, monitoring, biomanufacturing and cell and gene therapy technologies. The company plays a key role in delivering healthcare solutions globally.
GE Healthcare Technologies shares traded at $78.7 on the day of trading. The company's market capitalization is approximately $35.81 billion. Its price-to-earnings ratio of 22.94 is below the industry average of 25.84, suggesting a potentially favorable valuation relative to its peers.
The insider trading history for GE HealthCare Technologies Inc over the past year shows a trend of 1 insider purchases and 4 sales. Taha Kass-hout sold a total of 3,300 shares and made no purchases during the period.
For more detailed valuation metrics, investors may want to consider looking at GE Healthcare Technologies' GF Value, price-to-sales multiple, price-to-book multiple, and price-to-free cash flow multiple.
This insider sale could be part of personal portfolio management or other financial considerations. Investors often monitor insider transactions because they can tell them how the company's chief executive officer views the stock's valuation and future prospects.
This article written by GuruFocus is intended to provide general insights and is not tailored financial advice. Our commentary is based on historical data and analyst forecasts, uses an unbiased methodology and is not intended to serve as specific investment guidance. It is not a recommendation to buy or sell stocks, nor does it take into account individual investment objectives or financial situation. Our objective is to provide long-term, fundamental data-driven analysis. Please note that our analysis may not incorporate the latest price-sensitive company announcements or qualitative information. GuruFocus has no position in the stocks mentioned herein.
This article was originally published on GuruFocus.
